# Theophylline in Rhinitis

> **NCT01132781** · PHASE2 · COMPLETED · sponsor: **University of East Anglia** · enrollment: 28 (actual)

## Conditions studied

- Rhinosinusitis
- Asthma
- Allergic Rhinitis

## Interventions

- **DRUG:** Theophylline (Intervention Group)
- **DRUG:** Placebo (Placebo Group)

## Key facts

- **NCT ID:** NCT01132781
- **Lead sponsor:** University of East Anglia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132781, "Theophylline in Rhinitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01132781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*